1. Home
  2. ROAD vs CNTA Comparison

ROAD vs CNTA Comparison

Compare ROAD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$115.80

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.45

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
CNTA
Founded
2001
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.1B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ROAD
CNTA
Price
$115.80
$39.45
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$127.80
$43.17
AVG Volume (30 Days)
419.1K
4.9M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
29.13
EPS
0.31
N/A
Revenue
$785,679,000.00
$15,000,000.00
Revenue This Year
$27.79
N/A
Revenue Next Year
$10.29
N/A
P/E Ratio
$376.03
N/A
Revenue Growth
0.31
N/A
52 Week Low
$83.20
$10.95
52 Week High
$141.90
$40.26

Technical Indicators

Market Signals
Indicator
ROAD
CNTA
Relative Strength Index (RSI) 47.33 73.18
Support Level $113.03 $39.16
Resistance Level $116.48 $40.26
Average True Range (ATR) 5.31 0.20
MACD 0.14 -0.47
Stochastic Oscillator 27.74 47.54

Price Performance

Historical Comparison
ROAD
CNTA

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: